Matches in Wikidata for { <http://www.wikidata.org/entity/Q92910135> ?p ?o ?g. }
Showing items 1 to 39 of
39
with 100 items per page.
- Q92910135 description "article scientifique publié en 2020" @default.
- Q92910135 description "artículu científicu espublizáu en xineru de 2020" @default.
- Q92910135 description "im Januar 2020 veröffentlichter wissenschaftlicher Artikel" @default.
- Q92910135 description "scientific article published on 20 January 2020" @default.
- Q92910135 description "wetenschappelijk artikel" @default.
- Q92910135 description "наукова стаття, опублікована 20 січня 2020" @default.
- Q92910135 name "A randomized, crossover trial comparing the efficacy and safety of fesoterodine and extended-release oxybutynin in children with overactive bladder with 12-month extension on fesoterodine: The FOXY study" @default.
- Q92910135 name "A randomized, crossover trial comparing the efficacy and safety of fesoterodine and extended-release oxybutynin in children with overactive bladder with 12-month extension on fesoterodine: The FOXY study" @default.
- Q92910135 type Item @default.
- Q92910135 label "A randomized, crossover trial comparing the efficacy and safety of fesoterodine and extended-release oxybutynin in children with overactive bladder with 12-month extension on fesoterodine: The FOXY study" @default.
- Q92910135 label "A randomized, crossover trial comparing the efficacy and safety of fesoterodine and extended-release oxybutynin in children with overactive bladder with 12-month extension on fesoterodine: The FOXY study" @default.
- Q92910135 prefLabel "A randomized, crossover trial comparing the efficacy and safety of fesoterodine and extended-release oxybutynin in children with overactive bladder with 12-month extension on fesoterodine: The FOXY study" @default.
- Q92910135 prefLabel "A randomized, crossover trial comparing the efficacy and safety of fesoterodine and extended-release oxybutynin in children with overactive bladder with 12-month extension on fesoterodine: The FOXY study" @default.
- Q92910135 P1433 Q92910135-ACFBE411-9C4D-47BC-805E-F8F38454D776 @default.
- Q92910135 P1476 Q92910135-F67C313A-383D-444B-BF84-5DD0E556BF93 @default.
- Q92910135 P2093 Q92910135-0F8E0FB4-C6A7-416D-8D05-F81028558786 @default.
- Q92910135 P2093 Q92910135-2114F611-0FBC-4150-A889-79C894D52905 @default.
- Q92910135 P2093 Q92910135-22FFC757-9167-4784-858E-3F7CD6F4B174 @default.
- Q92910135 P2093 Q92910135-2887E473-283D-4B6E-87D3-815CF04C9AB2 @default.
- Q92910135 P2093 Q92910135-29B0928B-D410-4869-AE34-AD9BC79C6C27 @default.
- Q92910135 P31 Q92910135-50EBE531-7269-4B04-A112-A99FF26C1C1C @default.
- Q92910135 P356 Q92910135-47104711-61C8-4360-A774-856717C63B73 @default.
- Q92910135 P577 Q92910135-DCD09924-BAB1-40ED-93F2-B94AB6B22E6C @default.
- Q92910135 P698 Q92910135-3744C333-5567-42AE-AA2F-8BAD64694ADA @default.
- Q92910135 P932 Q92910135-78C863A5-37DD-4FD5-8E8D-1E9231E647D8 @default.
- Q92910135 P356 CUAJ.6247 @default.
- Q92910135 P698 31977308 @default.
- Q92910135 P1433 Q26842808 @default.
- Q92910135 P1476 "A randomized, crossover trial comparing the efficacy and safety of fesoterodine and extended-release oxybutynin in children with overactive bladder with 12-month extension on fesoterodine: The FOXY study" @default.
- Q92910135 P2093 "David Simonyan" @default.
- Q92910135 P2093 "Katherine Moore" @default.
- Q92910135 P2093 "Sophie Ramsay" @default.
- Q92910135 P2093 "Stéphane Bolduc" @default.
- Q92910135 P2093 "Élizabeth Naud" @default.
- Q92910135 P31 Q13442814 @default.
- Q92910135 P356 "10.5489/CUAJ.6247" @default.
- Q92910135 P577 "2020-01-20T00:00:00Z" @default.
- Q92910135 P698 "31977308" @default.
- Q92910135 P932 "7654663" @default.